These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22901018)

  • 21. Point-of-Care Clinical Trials in Sports Medicine Research: Identifying Effective Treatment Interventions Through Comparative Effectiveness Research.
    Lam KC; Bacon CEW; Sauers EL; Bay RC
    J Athl Train; 2020 Mar; 55(3):217-228. PubMed ID: 31618071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innovative designs of point-of-care comparative effectiveness trials.
    Shih MC; Turakhia M; Lai TL
    Contemp Clin Trials; 2015 Nov; 45(Pt A):61-8. PubMed ID: 26099528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How changes in drug-safety regulations affect the way drug and biotech companies invest in innovation.
    Reed SD; Califf RM; Schulman KA
    Health Aff (Millwood); 2006; 25(5):1309-17. PubMed ID: 16966727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exceptional economic returns on investments in medical research.
    Rosenberg LE
    Med J Aust; 2002 Oct; 177(7):368-71. PubMed ID: 12358580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Company stock prices before and after public announcements related to oncology drugs.
    Rothenstein JM; Tomlinson G; Tannock IF; Detsky AS
    J Natl Cancer Inst; 2011 Oct; 103(20):1507-12. PubMed ID: 21949081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facts, fallacies, and politics of comparative effectiveness research: Part I. Basic considerations.
    Manchikanti L; Falco FJ; Boswell MV; Hirsch JA
    Pain Physician; 2010; 13(1):E23-54. PubMed ID: 20119474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating collaborations in comparative effectiveness research: opportunities and challenges for social network analysis.
    Zickafoose JS; Kimmey LD; Tomas A; Esposito D; Rich E
    J Comp Eff Res; 2014 Nov; 3(6):667-75. PubMed ID: 25494573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Private investment in AIDS vaccine development: obstacles and solutions.
    Batson A; Ainsworth M
    Bull World Health Organ; 2001; 79(8):721-7. PubMed ID: 11545328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects.
    Simonds NI; Khoury MJ; Schully SD; Armstrong K; Cohn WF; Fenstermacher DA; Ginsburg GS; Goddard KA; Knaus WA; Lyman GH; Ramsey SD; Xu J; Freedman AN
    J Natl Cancer Inst; 2013 Jul; 105(13):929-36. PubMed ID: 23661804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effectiveness regulations and pharmaceutical innovation.
    Vernon JA; Golec JH; Stevens JS
    Pharmacoeconomics; 2010; 28(10):877-87. PubMed ID: 20831295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare ROI. Medical research, comparative-effectiveness studies deserve investment.
    May D
    Mod Healthc; 2013 Feb; 43(8):23. PubMed ID: 23516786
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative effectiveness research in lung diseases and sleep disorders: recommendations from the National Heart, Lung, and Blood Institute workshop.
    Lieu TA; Au D; Krishnan JA; Moss M; Selker H; Harabin A; Taggart V; Connors A;
    Am J Respir Crit Care Med; 2011 Oct; 184(7):848-56. PubMed ID: 21965016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anatomy of medical research: US and international comparisons.
    Moses H; Matheson DH; Cairns-Smith S; George BP; Palisch C; Dorsey ER
    JAMA; 2015 Jan; 313(2):174-89. PubMed ID: 25585329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of comparative effectiveness research in Asia, Europe, and North America.
    Patel I; Rarus R; Tan X; Lee EK; Guy J; Ahmad A; Chang J
    Indian J Pharmacol; 2015; 47(6):585-93. PubMed ID: 26729947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost, coverage, and comparative effectiveness research: the critical issues for oncology.
    Pearson SD
    J Clin Oncol; 2012 Dec; 30(34):4275-81. PubMed ID: 23071229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of clinical trials in comparative effectiveness research on mental health.
    Blanco C; Rafful C; Olfson M
    J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S29-36. PubMed ID: 23849150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.
    Chalkidou K; Tunis S; Whicher D; Fowler R; Zwarenstein M
    Clin Trials; 2012 Aug; 9(4):436-46. PubMed ID: 22752634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. American Recovery and Reinvestment Act investments in data infrastructure.
    O'Day B; Kieffer T; Forrestal S; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):591-600. PubMed ID: 25494565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Canada Pension Plan's experience with investing its portfolio in equities.
    Sarney M; Preneta AM
    Soc Secur Bull; 2001-2002; 64(2):46-56. PubMed ID: 12428509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.